The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Safety Pharmacology Market Research Report 2025
Synopsis
The global Safety Pharmacology market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Safety Pharmacology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Safety Pharmacology.
Report Scope
The Safety Pharmacology market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Safety Pharmacology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Safety Pharmacology companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
PerkinElmer
Merck
Charles River
TKTsweden
Pharmaron
Reaction Biology
Eurofins Discovery
Frontage Laboratories
Tergus Pharma
QIMA Life Sciences
Segment by Type
Respiratory System
Central Nervous System
Cardiovascular System
Medical Device Safety Evaluation
Natural Product Safety Evaluation
Others
Segment by Application
Large Animal Species
Small Animal Species
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Safety Pharmacology companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Safety Pharmacology market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Safety Pharmacology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Safety Pharmacology.
Report Scope
The Safety Pharmacology market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Safety Pharmacology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Safety Pharmacology companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
PerkinElmer
Merck
Charles River
TKTsweden
Pharmaron
Reaction Biology
Eurofins Discovery
Frontage Laboratories
Tergus Pharma
QIMA Life Sciences
Segment by Type
Respiratory System
Central Nervous System
Cardiovascular System
Medical Device Safety Evaluation
Natural Product Safety Evaluation
Others
Segment by Application
Large Animal Species
Small Animal Species
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Safety Pharmacology companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Safety Pharmacology Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Respiratory System
1.2.3 Central Nervous System
1.2.4 Cardiovascular System
1.2.5 Medical Device Safety Evaluation
1.2.6 Natural Product Safety Evaluation
1.2.7 Others
1.3 Market by Application
1.3.1 Global Safety Pharmacology Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Large Animal Species
1.3.3 Small Animal Species
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Safety Pharmacology Market Perspective (2019-2030)
2.2 Safety Pharmacology Growth Trends by Region
2.2.1 Global Safety Pharmacology Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Safety Pharmacology Historic Market Size by Region (2019-2024)
2.2.3 Safety Pharmacology Forecasted Market Size by Region (2025-2030)
2.3 Safety Pharmacology Market Dynamics
2.3.1 Safety Pharmacology Industry Trends
2.3.2 Safety Pharmacology Market Drivers
2.3.3 Safety Pharmacology Market Challenges
2.3.4 Safety Pharmacology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Safety Pharmacology Players by Revenue
3.1.1 Global Top Safety Pharmacology Players by Revenue (2019-2024)
3.1.2 Global Safety Pharmacology Revenue Market Share by Players (2019-2024)
3.2 Global Safety Pharmacology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Safety Pharmacology Revenue
3.4 Global Safety Pharmacology Market Concentration Ratio
3.4.1 Global Safety Pharmacology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Safety Pharmacology Revenue in 2023
3.5 Safety Pharmacology Key Players Head office and Area Served
3.6 Key Players Safety Pharmacology Product Solution and Service
3.7 Date of Enter into Safety Pharmacology Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Safety Pharmacology Breakdown Data by Type
4.1 Global Safety Pharmacology Historic Market Size by Type (2019-2024)
4.2 Global Safety Pharmacology Forecasted Market Size by Type (2025-2030)
5 Safety Pharmacology Breakdown Data by Application
5.1 Global Safety Pharmacology Historic Market Size by Application (2019-2024)
5.2 Global Safety Pharmacology Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Safety Pharmacology Market Size (2019-2030)
6.2 North America Safety Pharmacology Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Safety Pharmacology Market Size by Country (2019-2024)
6.4 North America Safety Pharmacology Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Safety Pharmacology Market Size (2019-2030)
7.2 Europe Safety Pharmacology Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Safety Pharmacology Market Size by Country (2019-2024)
7.4 Europe Safety Pharmacology Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Safety Pharmacology Market Size (2019-2030)
8.2 Asia-Pacific Safety Pharmacology Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Safety Pharmacology Market Size by Region (2019-2024)
8.4 Asia-Pacific Safety Pharmacology Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Safety Pharmacology Market Size (2019-2030)
9.2 Latin America Safety Pharmacology Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Safety Pharmacology Market Size by Country (2019-2024)
9.4 Latin America Safety Pharmacology Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Safety Pharmacology Market Size (2019-2030)
10.2 Middle East & Africa Safety Pharmacology Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Safety Pharmacology Market Size by Country (2019-2024)
10.4 Middle East & Africa Safety Pharmacology Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Safety Pharmacology Introduction
11.1.4 Thermo Fisher Scientific Revenue in Safety Pharmacology Business (2019-2024)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 PerkinElmer
11.2.1 PerkinElmer Company Detail
11.2.2 PerkinElmer Business Overview
11.2.3 PerkinElmer Safety Pharmacology Introduction
11.2.4 PerkinElmer Revenue in Safety Pharmacology Business (2019-2024)
11.2.5 PerkinElmer Recent Development
11.3 Merck
11.3.1 Merck Company Detail
11.3.2 Merck Business Overview
11.3.3 Merck Safety Pharmacology Introduction
11.3.4 Merck Revenue in Safety Pharmacology Business (2019-2024)
11.3.5 Merck Recent Development
11.4 Charles River
11.4.1 Charles River Company Detail
11.4.2 Charles River Business Overview
11.4.3 Charles River Safety Pharmacology Introduction
11.4.4 Charles River Revenue in Safety Pharmacology Business (2019-2024)
11.4.5 Charles River Recent Development
11.5 TKTsweden
11.5.1 TKTsweden Company Detail
11.5.2 TKTsweden Business Overview
11.5.3 TKTsweden Safety Pharmacology Introduction
11.5.4 TKTsweden Revenue in Safety Pharmacology Business (2019-2024)
11.5.5 TKTsweden Recent Development
11.6 Pharmaron
11.6.1 Pharmaron Company Detail
11.6.2 Pharmaron Business Overview
11.6.3 Pharmaron Safety Pharmacology Introduction
11.6.4 Pharmaron Revenue in Safety Pharmacology Business (2019-2024)
11.6.5 Pharmaron Recent Development
11.7 Reaction Biology
11.7.1 Reaction Biology Company Detail
11.7.2 Reaction Biology Business Overview
11.7.3 Reaction Biology Safety Pharmacology Introduction
11.7.4 Reaction Biology Revenue in Safety Pharmacology Business (2019-2024)
11.7.5 Reaction Biology Recent Development
11.8 Eurofins Discovery
11.8.1 Eurofins Discovery Company Detail
11.8.2 Eurofins Discovery Business Overview
11.8.3 Eurofins Discovery Safety Pharmacology Introduction
11.8.4 Eurofins Discovery Revenue in Safety Pharmacology Business (2019-2024)
11.8.5 Eurofins Discovery Recent Development
11.9 Frontage Laboratories
11.9.1 Frontage Laboratories Company Detail
11.9.2 Frontage Laboratories Business Overview
11.9.3 Frontage Laboratories Safety Pharmacology Introduction
11.9.4 Frontage Laboratories Revenue in Safety Pharmacology Business (2019-2024)
11.9.5 Frontage Laboratories Recent Development
11.10 Tergus Pharma
11.10.1 Tergus Pharma Company Detail
11.10.2 Tergus Pharma Business Overview
11.10.3 Tergus Pharma Safety Pharmacology Introduction
11.10.4 Tergus Pharma Revenue in Safety Pharmacology Business (2019-2024)
11.10.5 Tergus Pharma Recent Development
11.11 QIMA Life Sciences
11.11.1 QIMA Life Sciences Company Detail
11.11.2 QIMA Life Sciences Business Overview
11.11.3 QIMA Life Sciences Safety Pharmacology Introduction
11.11.4 QIMA Life Sciences Revenue in Safety Pharmacology Business (2019-2024)
11.11.5 QIMA Life Sciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Safety Pharmacology Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Respiratory System
Table 3. Key Players of Central Nervous System
Table 4. Key Players of Cardiovascular System
Table 5. Key Players of Medical Device Safety Evaluation
Table 6. Key Players of Natural Product Safety Evaluation
Table 7. Key Players of Others
Table 8. Global Safety Pharmacology Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Safety Pharmacology Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global Safety Pharmacology Market Size by Region (2019-2024) & (US$ Million)
Table 11. Global Safety Pharmacology Market Share by Region (2019-2024)
Table 12. Global Safety Pharmacology Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 13. Global Safety Pharmacology Market Share by Region (2025-2030)
Table 14. Safety Pharmacology Market Trends
Table 15. Safety Pharmacology Market Drivers
Table 16. Safety Pharmacology Market Challenges
Table 17. Safety Pharmacology Market Restraints
Table 18. Global Safety Pharmacology Revenue by Players (2019-2024) & (US$ Million)
Table 19. Global Safety Pharmacology Market Share by Players (2019-2024)
Table 20. Global Top Safety Pharmacology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Safety Pharmacology as of 2023)
Table 21. Ranking of Global Top Safety Pharmacology Companies by Revenue (US$ Million) in 2023
Table 22. Global 5 Largest Players Market Share by Safety Pharmacology Revenue (CR5 and HHI) & (2019-2024)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Safety Pharmacology Product Solution and Service
Table 25. Date of Enter into Safety Pharmacology Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Safety Pharmacology Market Size by Type (2019-2024) & (US$ Million)
Table 28. Global Safety Pharmacology Revenue Market Share by Type (2019-2024)
Table 29. Global Safety Pharmacology Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 30. Global Safety Pharmacology Revenue Market Share by Type (2025-2030)
Table 31. Global Safety Pharmacology Market Size by Application (2019-2024) & (US$ Million)
Table 32. Global Safety Pharmacology Revenue Market Share by Application (2019-2024)
Table 33. Global Safety Pharmacology Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 34. Global Safety Pharmacology Revenue Market Share by Application (2025-2030)
Table 35. North America Safety Pharmacology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America Safety Pharmacology Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America Safety Pharmacology Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe Safety Pharmacology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. Europe Safety Pharmacology Market Size by Country (2019-2024) & (US$ Million)
Table 40. Europe Safety Pharmacology Market Size by Country (2025-2030) & (US$ Million)
Table 41. Asia-Pacific Safety Pharmacology Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 42. Asia-Pacific Safety Pharmacology Market Size by Region (2019-2024) & (US$ Million)
Table 43. Asia-Pacific Safety Pharmacology Market Size by Region (2025-2030) & (US$ Million)
Table 44. Latin America Safety Pharmacology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Latin America Safety Pharmacology Market Size by Country (2019-2024) & (US$ Million)
Table 46. Latin America Safety Pharmacology Market Size by Country (2025-2030) & (US$ Million)
Table 47. Middle East & Africa Safety Pharmacology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 48. Middle East & Africa Safety Pharmacology Market Size by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Safety Pharmacology Market Size by Country (2025-2030) & (US$ Million)
Table 50. Thermo Fisher Scientific Company Detail
Table 51. Thermo Fisher Scientific Business Overview
Table 52. Thermo Fisher Scientific Safety Pharmacology Product
Table 53. Thermo Fisher Scientific Revenue in Safety Pharmacology Business (2019-2024) & (US$ Million)
Table 54. Thermo Fisher Scientific Recent Development
Table 55. PerkinElmer Company Detail
Table 56. PerkinElmer Business Overview
Table 57. PerkinElmer Safety Pharmacology Product
Table 58. PerkinElmer Revenue in Safety Pharmacology Business (2019-2024) & (US$ Million)
Table 59. PerkinElmer Recent Development
Table 60. Merck Company Detail
Table 61. Merck Business Overview
Table 62. Merck Safety Pharmacology Product
Table 63. Merck Revenue in Safety Pharmacology Business (2019-2024) & (US$ Million)
Table 64. Merck Recent Development
Table 65. Charles River Company Detail
Table 66. Charles River Business Overview
Table 67. Charles River Safety Pharmacology Product
Table 68. Charles River Revenue in Safety Pharmacology Business (2019-2024) & (US$ Million)
Table 69. Charles River Recent Development
Table 70. TKTsweden Company Detail
Table 71. TKTsweden Business Overview
Table 72. TKTsweden Safety Pharmacology Product
Table 73. TKTsweden Revenue in Safety Pharmacology Business (2019-2024) & (US$ Million)
Table 74. TKTsweden Recent Development
Table 75. Pharmaron Company Detail
Table 76. Pharmaron Business Overview
Table 77. Pharmaron Safety Pharmacology Product
Table 78. Pharmaron Revenue in Safety Pharmacology Business (2019-2024) & (US$ Million)
Table 79. Pharmaron Recent Development
Table 80. Reaction Biology Company Detail
Table 81. Reaction Biology Business Overview
Table 82. Reaction Biology Safety Pharmacology Product
Table 83. Reaction Biology Revenue in Safety Pharmacology Business (2019-2024) & (US$ Million)
Table 84. Reaction Biology Recent Development
Table 85. Eurofins Discovery Company Detail
Table 86. Eurofins Discovery Business Overview
Table 87. Eurofins Discovery Safety Pharmacology Product
Table 88. Eurofins Discovery Revenue in Safety Pharmacology Business (2019-2024) & (US$ Million)
Table 89. Eurofins Discovery Recent Development
Table 90. Frontage Laboratories Company Detail
Table 91. Frontage Laboratories Business Overview
Table 92. Frontage Laboratories Safety Pharmacology Product
Table 93. Frontage Laboratories Revenue in Safety Pharmacology Business (2019-2024) & (US$ Million)
Table 94. Frontage Laboratories Recent Development
Table 95. Tergus Pharma Company Detail
Table 96. Tergus Pharma Business Overview
Table 97. Tergus Pharma Safety Pharmacology Product
Table 98. Tergus Pharma Revenue in Safety Pharmacology Business (2019-2024) & (US$ Million)
Table 99. Tergus Pharma Recent Development
Table 100. QIMA Life Sciences Company Detail
Table 101. QIMA Life Sciences Business Overview
Table 102. QIMA Life Sciences Safety Pharmacology Product
Table 103. QIMA Life Sciences Revenue in Safety Pharmacology Business (2019-2024) & (US$ Million)
Table 104. QIMA Life Sciences Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Safety Pharmacology Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Safety Pharmacology Market Share by Type: 2023 VS 2030
Figure 3. Respiratory System Features
Figure 4. Central Nervous System Features
Figure 5. Cardiovascular System Features
Figure 6. Medical Device Safety Evaluation Features
Figure 7. Natural Product Safety Evaluation Features
Figure 8. Others Features
Figure 9. Global Safety Pharmacology Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Safety Pharmacology Market Share by Application: 2023 VS 2030
Figure 11. Large Animal Species Case Studies
Figure 12. Small Animal Species Case Studies
Figure 13. Safety Pharmacology Report Years Considered
Figure 14. Global Safety Pharmacology Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Safety Pharmacology Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Safety Pharmacology Market Share by Region: 2023 VS 2030
Figure 17. Global Safety Pharmacology Market Share by Players in 2023
Figure 18. Global Top Safety Pharmacology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Safety Pharmacology as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Safety Pharmacology Revenue in 2023
Figure 20. North America Safety Pharmacology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Safety Pharmacology Market Share by Country (2019-2030)
Figure 22. United States Safety Pharmacology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Safety Pharmacology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Safety Pharmacology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Safety Pharmacology Market Share by Country (2019-2030)
Figure 26. Germany Safety Pharmacology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Safety Pharmacology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Safety Pharmacology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Safety Pharmacology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Safety Pharmacology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Safety Pharmacology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Safety Pharmacology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Safety Pharmacology Market Share by Region (2019-2030)
Figure 34. China Safety Pharmacology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Safety Pharmacology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Safety Pharmacology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Safety Pharmacology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Safety Pharmacology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Safety Pharmacology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Safety Pharmacology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Safety Pharmacology Market Share by Country (2019-2030)
Figure 42. Mexico Safety Pharmacology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Safety Pharmacology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Safety Pharmacology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Safety Pharmacology Market Share by Country (2019-2030)
Figure 46. Turkey Safety Pharmacology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Safety Pharmacology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Thermo Fisher Scientific Revenue Growth Rate in Safety Pharmacology Business (2019-2024)
Figure 49. PerkinElmer Revenue Growth Rate in Safety Pharmacology Business (2019-2024)
Figure 50. Merck Revenue Growth Rate in Safety Pharmacology Business (2019-2024)
Figure 51. Charles River Revenue Growth Rate in Safety Pharmacology Business (2019-2024)
Figure 52. TKTsweden Revenue Growth Rate in Safety Pharmacology Business (2019-2024)
Figure 53. Pharmaron Revenue Growth Rate in Safety Pharmacology Business (2019-2024)
Figure 54. Reaction Biology Revenue Growth Rate in Safety Pharmacology Business (2019-2024)
Figure 55. Eurofins Discovery Revenue Growth Rate in Safety Pharmacology Business (2019-2024)
Figure 56. Frontage Laboratories Revenue Growth Rate in Safety Pharmacology Business (2019-2024)
Figure 57. Tergus Pharma Revenue Growth Rate in Safety Pharmacology Business (2019-2024)
Figure 58. QIMA Life Sciences Revenue Growth Rate in Safety Pharmacology Business (2019-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
